WHO officials call for continuing the measures adopted to deal with the Covid delta variant against the Omicron
Much remains unknown about the new variant, including whether it is more contagious, as some health authorities suspect, or if it makes people more seriously ill, and whether it can thwart the vaccine.
While a few regional countries are facing surges, Covid-19 cases and deaths in many others have decreased and plateaued, WHO Regional Director for the Western Pacific Dr. Takeshi Kasai told reporters Friday in a virtual news conference broadcast from Manila, Philippines. “The positive news in all of this is that none of the information we have currently about omicron suggests we need to change the directions of our response."
Kasai said omicron has been designated a variant of concern because of the number of mutations and because early information suggests it may be more transmissible than other variants of the virus. Will travel bans halt the spread of Omicron?
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Why scientists — and much of the world — reacted so quickly to the omicron variantThese early signs made omicron different from previous Covid variants, experts say.
Les mer »
How Omicron Stacks Up Against the Delta Variant—Including Whether or Not We'll Need a New VaccineHow the two compare, according to the WHO and health professionals.
Les mer »
Biden will outline new steps to combat Covid through winter monthsThe White House is set to announce a slew of new actions Thursday aimed at fighting the Covid-19 pandemic and protecting Americans from the Delta and newly discovered Omicron variants.
Les mer »
Moderna Warns of ‘Material Drop’ in Vaccine Efficacy Against OmicronThe Moderna CEO says existing COVID-19 vaccines will likely be less effective against the new Omicron variant. “I think it’s going to be a material drop,” he said. “I just don’t know how much, because we need to wait for the data.'
Les mer »
COVID-19 Antibody Drug Likely Works Against Omicron, Companies SayEarly lab studies show that a COVID-19 antibody treatment developed by GlaxoSmithKline and Vir Biotechnology could be effective against the Omicron variant.
Les mer »
Factbox: What COVID-19 vaccine and drug makers have to say about OmicronThe Omicron variant of the coronavirus has sparked fears that existing COVID-19 vaccines and treatment could be less effective against it.
Les mer »